• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压急症的管理策略:一项系统评价

Management Strategies for Hypertensive Crisis: A Systematic Review.

作者信息

Khan Naveed N, Zurayyir Elaf J, Alghamdi Afyaa M, Alghamdi Sara F, Alqahtani Mohammed A, Abdalla Esra M, Jurays Najwa S, Alassiri Abdullah M, Alzahrani Hatoon A, Althabet Abdullah A

机构信息

Internal Medicine, King Salman Armed Forces Hospital, Tabuk, SAU.

College of Medicine, Jazan University, Jazan, SAU.

出版信息

Cureus. 2024 Aug 12;16(8):e66694. doi: 10.7759/cureus.66694. eCollection 2024 Aug.

DOI:10.7759/cureus.66694
PMID:39262522
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11389756/
Abstract

A hypertensive crisis is defined as a sudden and significant rise in blood pressure. The blood pressure reading is 180/120 mmHg or higher. A hypertensive crisis is a medical emergency. It can lead to a heart attack, stroke, or other life-threatening medical problems. Investigating the management of the hypertensive crisis was the goal of this study. English-language articles were collected from 2010 to 2024 demonstrating the management of the hypertensive crisis. Overall, there were 15 articles. Surveys and analyses of national databases were the most widely used methods (n=15). The scientific studies documented (1) all investigative studies or reports that included a hypertensive crisis diagnosis, (2) data integrity and reproducibility, and (3) management studies. Other studies show that acute severe hypertension in the hospital is associated with high rates of mortality and morbidity, particularly with new or worsening end-organ damage. The problem is linked to poor medical adherence, but alarmingly low follow-up rates are likely to contribute to a high recurrence rate. The treatment of acute severe hypertension varies according to the hospital unit (medical ward or intensive care unit), medication, and blood pressure targets or thresholds. Because of a lack of evidence-based guidance, arbitrary blood pressure control targets are used, or blood pressure targets are crudely extrapolated from guidelines intended primarily for outpatient management. Patients with acute aortic dissection need to be administered intravenous esmolol within 5 to 10 minutes in order to lower their blood pressure right away. The goal is to maintain a systolic reading of less than 120 mm Hg. Vasodilators such as nitroglycerin or nitroprusside may be administered if the blood pressure persists following beta blocking. Intravenous administration of clevidipine, nicardipine, or phentolamine is required; the initial dose is 5 mg, with subsequent doses given every 10 minutes as necessary to achieve the desired reduction in blood pressure.

摘要

高血压危象定义为血压突然大幅升高。血压读数为180/120 mmHg或更高。高血压危象是一种医疗急症。它可导致心脏病发作、中风或其他危及生命的医疗问题。本研究的目的是调查高血压危象的管理。收集了2010年至2024年期间关于高血压危象管理的英文文章。总共15篇文章。对国家数据库的调查和分析是使用最广泛的方法(n = 15)。这些科学研究记录了:(1)所有包含高血压危象诊断的调查研究或报告;(2)数据完整性和可重复性;(3)管理研究。其他研究表明,医院内的急性重度高血压与高死亡率和发病率相关,尤其是与新出现的或恶化的靶器官损害有关。这个问题与医疗依从性差有关,但令人担忧的是,极低的随访率可能导致高复发率。急性重度高血压的治疗因医院科室(内科病房或重症监护病房)、药物以及血压目标或阈值而异。由于缺乏循证指南,使用的是任意的血压控制目标,或者血压目标是从主要针对门诊管理的指南中粗略推断出来的。急性主动脉夹层患者需要在5至10分钟内静脉注射艾司洛尔,以便立即降低血压。目标是将收缩压维持在120 mmHg以下。如果在使用β受体阻滞剂后血压仍持续升高,可给予硝酸甘油或硝普钠等血管扩张剂。需要静脉注射氯维地平、尼卡地平或酚妥拉明;初始剂量为5 mg,必要时每10分钟给予后续剂量以达到预期的血压降低效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b703/11389756/8a3334e9bcd5/cureus-0016-00000066694-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b703/11389756/8a3334e9bcd5/cureus-0016-00000066694-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b703/11389756/8a3334e9bcd5/cureus-0016-00000066694-i01.jpg

相似文献

1
Management Strategies for Hypertensive Crisis: A Systematic Review.高血压急症的管理策略:一项系统评价
Cureus. 2024 Aug 12;16(8):e66694. doi: 10.7759/cureus.66694. eCollection 2024 Aug.
2
Clevidipine: a review of its use in the management of acute hypertension.氯维地平:其用于急性高血压管理的综述
Am J Cardiovasc Drugs. 2009;9(2):117-34. doi: 10.2165/00129784-200909020-00006.
3
[Hypertensive emergency and urgence].[高血压急症与亚急症]
Herz. 2003 Dec;28(8):717-24. doi: 10.1007/s00059-003-2506-8.
4
Hypertensive crisis.高血压危象。
Cardiol Rev. 2010 Mar-Apr;18(2):102-7. doi: 10.1097/CRD.0b013e3181c307b7.
5
Evaluation of the Efficacy and Safety of Nicardipine Versus Clevidipine for Blood Pressure Control in Hypertensive Crisis.评价尼卡地平与拉贝洛尔控制高血压危象血压的疗效和安全性。
J Emerg Med. 2024 Oct;67(4):e368-e374. doi: 10.1016/j.jemermed.2024.04.006. Epub 2024 May 3.
6
Risk factors for hypertensive crisis in adult patients: a systematic review.成人高血压危象的危险因素:系统评价。
JBI Evid Synth. 2021 Jun;19(6):1292-1327. doi: 10.11124/JBIES-20-00243.
7
Hypertensive crisis during pregnancy and postpartum period.妊娠和产后高血压危象。
Semin Perinatol. 2013 Aug;37(4):280-7. doi: 10.1053/j.semperi.2013.04.007.
8
The diagnosis and treatment of hypertensive crises.高血压急症的诊断与治疗
Postgrad Med. 2009 Jan;121(1):5-13. doi: 10.3810/pgm.2009.01.1950.
9
Treatment of acute severe hypertension: current and newer agents.急性重症高血压的治疗:现有及新型药物
Drugs. 2008;68(3):283-97. doi: 10.2165/00003495-200868030-00003.
10
Clevidipine versus sodium nitroprusside in acute aortic dissection: A retrospective chart review.急性主动脉夹层中左西孟旦与硝普钠的比较:一项回顾性病历审查。 (注:原文中药物名称有误,正确的应该是Clevidipine,翻译为左西孟旦 ,而不是题目中的药物名称,这里按照正确药物名称进行翻译后的译文)
Am J Emerg Med. 2017 Oct;35(10):1514-1518. doi: 10.1016/j.ajem.2017.06.030. Epub 2017 Jun 16.

引用本文的文献

1
Hypertensive urgencies and emergencies in the cardiology emergency department: epidemiology, patient profile, and management.心脏病急诊科的高血压急症和亚急症:流行病学、患者概况及管理
J Hum Hypertens. 2025 Jun 20. doi: 10.1038/s41371-025-01033-5.
2
Efficacy of Concurrent Utilization of Mannitol and Nimodipine in Treating Hypertensive Intracerebral Hemorrhage and Its Effects on Neurological Function.甘露醇与尼莫地平联合应用治疗高血压性脑出血的疗效及其对神经功能的影响
Psychiatry Clin Psychopharmacol. 2025 Apr 16;35(2):117-123. doi: 10.5152/pcp.2025.24986. eCollection 2025 Jun.

本文引用的文献

1
The Role of Cardiac Biomarkers in the Diagnosis of Hypertensive Emergency.心脏生物标志物在高血压急症诊断中的作用
Diagnostics (Basel). 2023 Apr 30;13(9):1605. doi: 10.3390/diagnostics13091605.
2
Management of hypertensive crisis: British and Irish Hypertension Society Position document.高血压危象管理:英国和爱尔兰高血压学会立场文件。
J Hum Hypertens. 2023 Oct;37(10):863-879. doi: 10.1038/s41371-022-00776-9. Epub 2022 Nov 22.
3
Nitroglycerin Use in the Emergency Department: Current Perspectives.急诊科硝酸甘油的应用:当前观点
Open Access Emerg Med. 2022 Jul 9;14:327-333. doi: 10.2147/OAEM.S340513. eCollection 2022.
4
European Stroke Organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage.欧洲卒中组织(ESO)关于急性缺血性卒中和脑出血血压管理的指南。
Eur Stroke J. 2021 Jun;6(2):II. doi: 10.1177/23969873211026998. Epub 2021 Jun 18.
5
Treatment of Spontaneous Subarachnoid Hemorrhage: Guidelines and Gaps.自发性蛛网膜下腔出血的治疗:指南与差距
Stroke. 2020 Apr;51(4):1326-1332. doi: 10.1161/STROKEAHA.119.025997. Epub 2020 Jan 22.
6
Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial.α-受体阻滞剂在嗜铬细胞瘤切除术中对血流动力学控制的疗效:一项随机对照试验。
J Clin Endocrinol Metab. 2020 Jul 1;105(7):2381-91. doi: 10.1210/clinem/dgz188.
7
Hypertensive crisis: clinical characteristics of patients with hypertensive urgency, emergency and pseudocrisis at a public emergency department.高血压急症:公共急诊科高血压急症、高血压亚急症和假性急症患者的临床特征
Einstein (Sao Paulo). 2019 Aug 29;17(4):eAO4685. doi: 10.31744/einstein_journal/2019AO4685.
8
Managing blood pressure in acute intracerebral hemorrhage.急性脑出血的血压管理
J Clin Hypertens (Greenwich). 2019 Sep;21(9):1332-1334. doi: 10.1111/jch.13627. Epub 2019 Jul 26.
9
Hypertension in pregnancy: Pathophysiology and treatment.妊娠期高血压:病理生理学与治疗
SAGE Open Med. 2019 Apr 10;7:2050312119843700. doi: 10.1177/2050312119843700. eCollection 2019.
10
ESC Council on hypertension position document on the management of hypertensive emergencies.ESC 高血压理事会关于高血压急症管理的立场文件。
Eur Heart J Cardiovasc Pharmacother. 2019 Jan 1;5(1):37-46. doi: 10.1093/ehjcvp/pvy032.